학술논문

The impact of olaparib dose reduction and treatment interruption on treatment outcome in the SOLO2/ENGOT-ov21 platinum-sensitive recurrent ovarian cancer
Document Type
Journal
Source
ANNALS OF ONCOLOGY; JUN 2022, 33 6, p593-p601, 9p.
Subject
Language
English
ISSN
15698041